Literature DB >> 11587050

Risk factors for renal failure: the WHO Mulinational Study of Vascular Disease in Diabetes.

H M Colhoun1, E T Lee, P H Bennett, M Lu, H Keen, S L Wang, L K Stevens, J H Fuller.   

Abstract

AIMS/HYPOTHESIS: We aimed to examine risk factors for, and differences in, renal failure in diabetic patients from 10 centres.
METHODS: Risk factors for renal failure were examined in 3,558 diabetic patients who did not have renal disease at baseline in the WHO Multinational Study of Vascular Disease in Diabetes (WHO MSVDD).
RESULTS: In 959 subjects with Type I (insulin-dependent) diabetes mellitus and 2,559 with Type II (non-insulin-dependent) diabetes mellitus, the average follow-up was 8.4 years (+/- 2.7). By the end of the follow-up period 53 patients in the Type I diabetic group and 134 patients in the Type II diabetic group had developed renal failure (incidence rate 6.3:1,000 person years). Increasing age and duration of diabetes were associated with renal failure in Type II and Type I diabetes. In Type II diabetes duration of diabetes was a more important risk factor than age. In both Type I and Type II diabetic retinopathy and proteinuria were strongly associated with renal failure. Systolic blood pressure was associated with renal failure in Type I but not in Type II diabetic patients. ECG abnormalities at baseline, self-reported smoking and cholesterol were not associated with renal failure. Triglycerides were measured in a subset of centres. Among those with Type II, but not Type I diabetes, triglycerides were associated with renal failure independently of systolic blood pressure, proteinuria or retinopathy. In Type II diabetes fasting plasma glucose was associated with renal failure independently of other risk factors. CONCLUSION/
INTERPRETATION: We have confirmed the role of proteinuria and retinopathy as markers of renal failure and the importance of hyperglycaemia in renal failure in Type I and Type II diabetes. Plasma triglycerides seem to be an important predictor of renal failure in Type II diabetes. In Type I diabetes systolic blood pressure is an important predictor of renal failure.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11587050     DOI: 10.1007/pl00002939

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  14 in total

1.  End-stage renal disease risk equations for Hong Kong Chinese patients with type 2 diabetes: Hong Kong Diabetes Registry.

Authors:  X L Yang; W Y So; A P S Kong; P Clarke; C S Ho; C W K Lam; M H L Ng; R R Lyu; D D Yin; C C Chow; C S Cockram; P C Y Tong; J C N Chan
Journal:  Diabetologia       Date:  2006-08-30       Impact factor: 10.122

Review 2.  Dyslipidemia, kidney disease, and cardiovascular disease in diabetic patients.

Authors:  Szu-chi Chen; Chin-Hsiao Tseng
Journal:  Rev Diabet Stud       Date:  2013-08-10

Review 3.  PPARalpha: an emerging therapeutic target in diabetic microvascular damage.

Authors:  Anne Hiukka; Marianna Maranghi; Niina Matikainen; Marja-Riitta Taskinen
Journal:  Nat Rev Endocrinol       Date:  2010-06-22       Impact factor: 43.330

4.  Estimated glomerular filtration rate and albuminuria are independent predictors of cardiovascular events and death in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.

Authors:  P L Drury; R Ting; D Zannino; C Ehnholm; J Flack; M Whiting; R Fassett; J-C Ansquer; P Dixon; T M E Davis; C Pardy; P Colman; A Keech
Journal:  Diabetologia       Date:  2010-07-30       Impact factor: 10.122

5.  Hypertriglyceridemia and Other Risk Factors of Chronic Kidney Disease in Type 2 Diabetes: A Hospital-Based Clinic Population in Greece.

Authors:  Ilias N Migdalis; Ioannis M Ioannidis; Nikolaos Papanas; Athanasios E Raptis; Alexios E Sotiropoulos; George D Dimitriadis
Journal:  J Clin Med       Date:  2022-06-06       Impact factor: 4.964

6.  Saturated-fat diet induces moderate diabetes and severe glomerulosclerosis in hamsters.

Authors:  D Popov; M Simionescu; P R Shepherd
Journal:  Diabetologia       Date:  2003-07-29       Impact factor: 10.122

7.  Lipid abnormalities predict progression of renal disease in patients with type 1 diabetes.

Authors:  N Tolonen; C Forsblom; L Thorn; J Wadén; M Rosengård-Bärlund; M Saraheimo; M Feodoroff; V-P Mäkinen; D Gordin; M-R Taskinen; P-H Groop
Journal:  Diabetologia       Date:  2009-10-10       Impact factor: 10.122

8.  The renoprotective actions of peroxisome proliferator-activated receptors agonists in diabetes.

Authors:  M C Thomas; K A Jandeleit-Dahm; C Tikellis
Journal:  PPAR Res       Date:  2012-02-12       Impact factor: 4.964

9.  Effects of long-term fenofibrate treatment on markers of renal function in type 2 diabetes: the FIELD Helsinki substudy.

Authors:  Carol Forsblom; Anne Hiukka; Eeva S Leinonen; Jouko Sundvall; Per-Henrik Groop; Marja-Riitta Taskinen
Journal:  Diabetes Care       Date:  2009-10-21       Impact factor: 19.112

10.  Joint relationship between renal function and proteinuria on mortality of patients with type 2 diabetes: the Taichung Diabetes Study.

Authors:  Cheng-Chieh Lin; Ching-Chu Chen; Pei-Tseng Kung; Chia-Ing Li; Sing-Yu Yang; Chiu-Shong Liu; Wen-Yuan Lin; Cheng-Chun Lee; Tsai-Chung Li; Sharon L R Kardia
Journal:  Cardiovasc Diabetol       Date:  2012-10-19       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.